Trials / Sponsors / Nanjing Tianyinshan Hospital
Nanjing Tianyinshan Hospital
Academic / Other · 3 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC NSCLC | — | 2026-04-10 |
| Recruiting | Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma(HCC) | N/A | 2025-05-22 |
| Not Yet Recruiting | Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients NSCLC | EARLY_Phase 1 | — |